Efficacy of Movement Breaks in Real-World Settings

March 4, 2025 updated by: Jonathan Little, University of British Columbia
The purpose of this study is to determine the efficacy of performing "exercise snacks" (short movement breaks throughout the day) on various measures of cardiometabolic health.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

After being informed about the study and potential risks, all eligible participants who have provided consent will undergo a baseline visit to assess pre-intervention basic anthropometrics, cardiorespiratory fitness, and provide a blood sample. Participants will then be randomized in a 1:1 ratio to one of two groups: 1) Mobility movement breaks (stretching or range of motion exercises); or 2) Cardiovascular movement breaks (designed to raise heart rate). Both groups will be encouraged to perform 3-4 daily movement breaks on at least 3 days of the week with support from an online platform and app that provides video instructions and reminders to complete the movement breaks. After 12 weeks, participants will be asked to return to the lab for the same testing performed at baseline.

Study Type

Interventional

Enrollment (Actual)

77

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Kelowna, British Columbia, Canada, V1V 1V7
        • University of British Columbia
    • Ontario
      • Hamilton, Ontario, Canada
        • McMaster University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Physically inactive (performing <150 minutes of moderate-to-vigorous intensity aerobic exercise per week, assessed by pre-screening Get Active Questionnaire);
  2. Body Mass Index: 18.5-30.0 kg/m2;
  3. Not currently diagnosed with or being treated for cardiometabolic disease (e.g., coronary artery disease, diabetes);
  4. Not a current smoker;
  5. Cleared to engage in physical activity using the Get Active Questionnaire and, if applicable, consultation with a Qualified Exercise Professional;
  6. Access to a computer, tablet or smartphone for intervention delivery and tracking

Exclusion Criteria:

  1. Chronic health condition preventing participation in exercise;
  2. Lack of access to internet connection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cardiovascular Movement Breaks
Participants will perform 3-4 exercise snacks (30-60s bursts of exercise) on at least 3 days of the week. The exercises prescribed in this arm will be designed to increase heart rate.
Participants will be asked to perform 30-60 second movement breaks 3-4 times per day on at least 3 days per week.
Other Names:
  • Activity Snacks
Active Comparator: Mobility Movement Breaks
Participants will perform 3-4 mobility snacks (30-60s of mobility exercises or stretching) on at least 3 days of the week. The exercises prescribed in this arm are not designed to increase heart rate.
Participants will be asked to perform 30-60 second movement breaks 3-4 times per day on at least 3 days per week.
Other Names:
  • Activity Snacks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Cardiorespiratory Fitness at 12 Weeks
Time Frame: Baseline and Week 12
Cardiorespiratory fitness will be assessed as the highest 30-s average from a laboratory-based graded VO2peak test on a cycle ergometer.
Baseline and Week 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Device-Measured Adherence to Movement Breaks
Time Frame: Week 2 and week 11
Participants will wear accelerometers to assess adherence near the beginning and the end of the intervention.
Week 2 and week 11
Self-Reported Adherence to Movement Breaks
Time Frame: Once per week for 12 weeks
Participants will be sent weekly surveys asking them to recall the total number of movement breaks performed that week.
Once per week for 12 weeks
Change From Baseline in Plasma Insulin
Time Frame: Baseline and 12 weeks
A fasted venous blood sample will be obtained and insulin measured by commercial assay.
Baseline and 12 weeks
Change From Baseline in Plasma Glucose
Time Frame: Baseline and 12 weeks
A fasted venous blood sample will be obtained and glucose measured by biochemical assay.
Baseline and 12 weeks
Change From Baseline in Insulin Resistance
Time Frame: Baseline and 12 weeks
A fasted venous blood sample will be obtained and insulin resistance estimated by homeostasis model assessment (HOMA) score
Baseline and 12 weeks
Change From Baseline in Inflammatory Cytokines
Time Frame: Baseline and 12 weeks
A fasted venous blood sample will be obtained and inflammatory cytokines measured by multiplex assay
Baseline and 12 weeks
Change From Baseline in Body Mass
Time Frame: Baseline and 12 weeks
Body mass will be measured by weigh scale
Baseline and 12 weeks
Change From Baseline in Waist Circumference
Time Frame: Baseline and 12 weeks
Waist circumference (in centimetres) will be measured using a measurement tape.
Baseline and 12 weeks
Movement Break Enjoyment Assessed by the Exercise Enjoyment Scale (EES)
Time Frame: Immediately following each movement break for entire 12-week intervention
The EES is a validated, single-item 7-point scale to assess exercise enjoyment. Possible scores range from 1 (not at all) to 7 (extremely).
Immediately following each movement break for entire 12-week intervention
Rating of Perceived Exertion (RPE) Following Movement Breaks
Time Frame: Immediately following each movement break for entire 12-week intervention
A 10 point RPE scale will be used to assess perceived exertion ranging from 0 (rest) to 10 (maximal).
Immediately following each movement break for entire 12-week intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jonathan Little, University of British Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Actual)

December 5, 2023

Study Completion (Actual)

December 5, 2023

Study Registration Dates

First Submitted

October 6, 2022

First Submitted That Met QC Criteria

October 6, 2022

First Posted (Actual)

October 10, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 4, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • H21-03417
  • 707246 (Other Grant/Funding Number: Canadian Cancer Society)
  • POC-181042 (Other Grant/Funding Number: Canadian Institutes of Health Research)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Movement Breaks

Subscribe